Literature DB >> 23220011

A role for β-dystroglycan in the organization and structure of the nucleus in myoblasts.

Ivette A Martínez-Vieyra1, Alejandra Vásquez-Limeta, Ricardo González-Ramírez, Sara L Morales-Lázaro, Mónica Mondragón, Ricardo Mondragón, Arturo Ortega, Steve J Winder, Bulmaro Cisneros.   

Abstract

We recently characterized a nuclear import pathway for β-dystroglycan; however, its nuclear role remains unknown. In this study, we demonstrate for the first time, the interaction of β-dystroglycan with distinct proteins from different nuclear compartments, including the nuclear envelope (NE) (emerin and lamins A/C and B1), splicing speckles (SC35), Cajal bodies (p80-coilin), and nucleoli (Nopp140). Electron microscopy analysis revealed that β-dystroglycan localized in the inner nuclear membrane, nucleoplasm, and nucleoli. Interestingly, downregulation of β-dystroglycan resulted in both mislocalization and decreased expression of emerin and lamin B1, but not lamin A/C, as well in disorganization of nucleoli, Cajal bodies, and splicing speckles with the concomitant decrease in the levels of Nopp140, and p80-coilin, but not SC35. Quantitative reverse transcription PCR and cycloheximide-mediated protein arrest assays revealed that β-dystroglycan deficiency did not change mRNA expression of NE proteins emerin and lamin B1 bud did alter their stability, accelerating protein turnover. Furthermore, knockdown of β-dystroglycan disrupted NE-mediated processes including nuclear morphology and centrosome-nucleus linkage, which provides evidence that β-dystroglycan association with NE proteins is biologically relevant. Unexpectedly, β-dystroglycan-depleted cells exhibited multiple centrosomes, a characteristic of cancerous cells. Overall, these findings imply that β-dystroglycan is a nuclear scaffolding protein involved in nuclear organization and NE structure and function, and that might be a contributor to the biogenesis of nuclear envelopathies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220011     DOI: 10.1016/j.bbamcr.2012.11.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Identification of Dp71 Isoforms Expressed in PC12 Cells: Subcellular Localization and Colocalization with β-Dystroglycan and α1-Syntrophin.

Authors:  Jorge Aragón; Alejandro Martínez-Herrera; José Romo-Yáñez; Víctor Ceja; Coztli Azotla-Vilchis; Lourdes Siqueiros-Márquez; Gabriela Soid-Raggi; Alma Herrera-Salazar; Cecilia Montañez
Journal:  J Mol Neurosci       Date:  2015-09-28       Impact factor: 3.444

2.  Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.

Authors:  G Mathew; A Mitchell; J M Down; L A Jacobs; F C Hamdy; C Eaton; D J Rosario; S S Cross; S J Winder
Journal:  Sci Rep       Date:  2013-09-30       Impact factor: 4.379

3.  Novel Nuclear Protein Complexes of Dystrophin 71 Isoforms in Rat Cultured Hippocampal GABAergic and Glutamatergic Neurons.

Authors:  Rafael Rodríguez-Muñoz; María Del Carmen Cárdenas-Aguayo; Víctor Alemán; Beatriz Osorio; Oscar Chávez-González; Alvaro Rendon; Dalila Martínez-Rojas; Marco Antonio Meraz-Ríos
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

Review 4.  The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy.

Authors:  Alec R Nickolls; Carsten G Bönnemann
Journal:  Dis Model Mech       Date:  2018-12-19       Impact factor: 5.758

5.  Nuclear import of β-dystroglycan is facilitated by ezrin-mediated cytoskeleton reorganization.

Authors:  Alejandra Vásquez-Limeta; Kylie M Wagstaff; Arturo Ortega; Dorothy H Crouch; David A Jans; Bulmaro Cisneros
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

6.  Expression pattern in retinal photoreceptors of POMGnT1, a protein involved in muscle-eye-brain disease.

Authors:  Mary Luz Uribe; Carmen Haro; María Paz Ventero; Laura Campello; Jesús Cruces; José Martín-Nieto
Journal:  Mol Vis       Date:  2016-06-16       Impact factor: 2.367

7.  Dystroglycan Depletion Impairs Actin-Dependent Functions of Differentiated Kasumi-1 Cells.

Authors:  Marco Antonio Escárcega-Tame; Ivette Martínez-Vieyra; Lea Alonso-Rangel; Bulmaro Cisneros; Steve J Winder; Doris Cerecedo
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

8.  γ-Secretase Dependent Nuclear Targeting of Dystroglycan.

Authors:  Daniel Leocadio; Andrew Mitchell; Steve J Winder
Journal:  J Cell Biochem       Date:  2016-03-31       Impact factor: 4.429

9.  Retrograde trafficking of β-dystroglycan from the plasma membrane to the nucleus.

Authors:  Viridiana Gracida-Jiménez; Ricardo Mondragón-González; Griselda Vélez-Aguilera; Alejandra Vásquez-Limeta; Marco S Laredo-Cisneros; Juan de Dios Gómez-López; Luis Vaca; Sarah C Gourlay; Laura A Jacobs; Steve J Winder; Bulmaro Cisneros
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

10.  Dasatinib as a treatment for Duchenne muscular dystrophy.

Authors:  Leanne Lipscomb; Robert W Piggott; Tracy Emmerson; Steve J Winder
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.